Previous reports highlighted that cancer-associated pathways, including the ERK-MAPK and PI3K-AKT, are activated as response to increased methylation levels in several mRNAs (Huang et al. 2021; Samatar and Poulikakos 2014; Sun et al. 2001). The gene discussed is AKT1; the disease is cancer.